麻豆影视

Skip to main content

Moderna has no plans to share its COVID-19 vaccine recipe

Share
ROME -

Moderna has no plans to share the recipe for its COVID-19 vaccine because executives have concluded that scaling up the company's own production is the best way to increase the global supply, the company's chairman said Monday.

In an interview with The Associated Press, Noubar Afeyan also reiterated a pledge Moderna made a year ago not to enforce patent infringement on anyone else making a coronavirus vaccine during the pandemic.

鈥淲e didn't have to do that,鈥 Afeyan said. 鈥漌e think that was the right, responsible thing to do.鈥 He added: 鈥淲e want that to be helping the world.鈥

The United Nations health agency has pressed Moderna to share its vaccine formula. Afeyan said the company analyzed whether it would be better to share the messenger RNA technology and determined that it could expand production and deliver billions of additional doses in 2022.

鈥淲ithin the next six to nine months, the most reliable way to make high-quality vaccines and in an efficient way is going to be if we make them,鈥 Afeyan said. Asked about appeals from the World Health Organization and others, he contended that such pleas assumed 鈥漷hat we couldn't get enough capacity, but in fact we know we can.鈥

Moderna 鈥渨ent from having zero production to having 1 billion doses in less than a year,鈥 Afeyan said, referring to the Massachusetts-based company's sprint to develop the vaccine and produce it in large quantities. 鈥淎nd we think we will be able to go from 1 to 3 billion鈥 in 2022.

鈥淲e think we are doing everything we can to help this pandemic,鈥 Afeyan added, citing the company's increasing output and its pledge on patent infringement.

He noted that $2.5 billion (about 2.1 billion euros) and 10 years were spent in developing the platform that makes Moderna's COVID-19 vaccine.

鈥淥thers joined the hunt when COVID-19 came along, and we're glad to see that the capacity therefore has been increased considerably beyond what Moderna would have been able to do鈥 by itself, Afeyan said.

Asked how successful he thought others might be if they started from scratch using Moderna patents, he declined to speculate. But 鈥渋t's hard for me to imagine that they would be able to get any meaningful scale in a short time frame at the quality we would be able to do as a certainty鈥 for 2022.

Asked about recent criticism that Moderna has been furnishing its vaccine mainly to wealthy countries while low-income countries clamor for the product, Afeyan said the company supplied a 鈥渜uite significant鈥 output to poorer nations, mostly through its work with the U.S. government, which contracted early in the pandemic with the company for doses.

Moderna is working with multiple governments 鈥渢o help them secure supplies for the express purpose of supplying to low-income countries,鈥 the executive said.

鈥淭here is more supply in the EU and the U.S. government than they will be able to use,鈥 said Afeyan, who is also a co-founder of Moderna.

Separately, Moderna made a commitment in May to Covax, the U.N.-backed vaccine program, to arrange for a total of 500 million does to go to poorer countries. He said probably 40 million doses would begin to ship in the last three months of this year, with the rest shipping next year.

The COVID-19 vaccine is Moderna's only commercial product. The company announced plans last week to open a vaccine plant somewhere in Africa. Afeyan said he hopes a decision will be made soon on an exact location. Still, it could take years to get the plant up and running.

Afeyan spoke on the last full day of a visit to Italy in which he met Pope Francis, who has appealed for universal vaccine access. He also appeared in Venice to promote a humanitarian prize.

Co-founded by Afeyan, the Aurora Humanitarian Initiative aims to 鈥渆mpower modern-day saviors to offer life and hope鈥 to those urgently needing basic humanitarian aid. Through the prize, the organization has awarded $5 million in grants to more than 30 humanitarian projects to help people recover from war, famine, genocide, human rights violations and other challenges.

CTVNews.ca Top Stories

How to win the fight with kids over phone use

The end of the day 鈥 when school, extracurricular activities and homework are (hopefully) finally done 鈥 is the window that many kids have for downtime. It can be a struggle to convince them not to go on their phones.

The London Police Service (LPS) is currently investigating a suspicious death in the east end.

Tattoos are becoming more common in today's society and, as a result, appear to be more acceptable in the workplace than they used to be.

Local Spotlight

Cole Haas is more than just an avid fan of the F.W. Johnson Wildcats football team. He's a fixture on the sidelines, a source of encouragement, and a beloved member of the team.

Getting a photograph of a rainbow? Common. Getting a photo of a lightning strike? Rare. Getting a photo of both at the same time? Extremely rare, but it happened to a Manitoba photographer this week.

An anonymous business owner paid off the mortgage for a New Brunswick not-for-profit.

They say a dog is a man鈥檚 best friend. In the case of Darren Cropper, from Bonfield, Ont., his three-year-old Siberian husky and golden retriever mix named Bear literally saved his life.

A growing group of brides and wedding photographers from across the province say they have been taken for tens of thousands of dollars by a Barrie, Ont. wedding photographer.

Paleontologists from the Royal B.C. Museum have uncovered "a trove of extraordinary fossils" high in the mountains of northern B.C., the museum announced Thursday.

The search for a missing ancient 28-year-old chocolate donkey ended with a tragic discovery Wednesday.

The Royal Canadian Mounted Police is celebrating an important milestone in the organization's history: 50 years since the first women joined the force.

It's been a whirlwind of joyful events for a northern Ontario couple who just welcomed a baby into their family and won the $70 million Lotto Max jackpot last month.

Stay Connected